Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1297 |
---|---|
Product Name | Anti-Human ANGPT2 Recombinant Antibody |
Molecular Name | Nesvacumab |
Alias | Anti-ANGPT2 Recombinant Antibody, Research Grade Nesvacumab |
CAS Number | 1296818-77-3 |
Target | ANGPT2[Homo sapiens] |
Isotype | IgG1 |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Buffer | PBS, pH7.5 |
Background | Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. As of May 2017, it is in Phase II clinical trials for the treatment of diabetic macular edema. This drug is being developed by Regeneron Pharmaceuticals. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |